While there were some IHC markers that are known to be more present in the stromal component (e.g. POSTN, COL11A1), our ovarian TMA was created to maximize the tumor epithelial tissue and the IHC scoring was based on the expression in the tumor epithelial compartment. This evidence concerns the gene COL11A1 and neoplasm.